Back to search results

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Melanoma · Medullary Thyroid Cancer · Sinonasal Undifferentiated Carcinoma · Esthesioneuroblastoma · Bladder Cancer · Testicular Cancer · Glioblastoma Multiforme · Cervical Cancer · Large Cell Neuroendocrine Carcinoma of the Lung · Non Small Cell Lung Cancer · Merkel Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Arizona Cancer Center at UMC North/University Medical Center, Tucson, Arizona, United States

    Contact: Study coordinator (Charles Hsu, MD) · cchsu@arizona.edu · 520-694-2347
    Contact: Study coordinator (Ricklie Julian, MD) · rickliej@arizona.edu · 520-694-2873
    Contact: Principal Investigator (Charles Hsu, MD)
    Ricklie Julian, MD (Sub-investigator)

  • University of Washington Fred Hutchinson Cancer Center, Seattle, Washington, United States

    Contact: Study coordinator (Shailender Bhatia, MD) · sbhatia@uw.edu · 206-606-6765
Study leads

  • Charles Hsu, MD

    Principal Investigator

    University of Arizona

  • Ricklie Julian, MD

    Study Chair

    University of Arizona

View source on ClinicalTrials.gov(opens in a new tab)